1.05
Revelation Biosciences Inc (REVB) 最新ニュース
Revelation Biosciences sets warrant expiration after stockholder approval - Investing.com
Why Revelation Biosciences Inc. stock remains a top recommendationJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Revelation Biosciences Has Reached A Quorum For Its December 3, 2025 Special Meeting - azcentral.com and The Arizona Republic
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment By Investing.com - Investing.com Canada
Revelation Biosciences, Inc. (REVB) -5.1% in After-hours: Amid Routine Trading Conditions - Stocks Telegraph
Revelation Biosciences shareholders approve warrant issuance and meeting adjournment - Investing.com
Revelation Biosciences (REVB) Stock Analysis Report | Financials & Insights - Benzinga
Revelation Biosciences (NASDAQ: REVB) secures quorum ahead of Dec. 3 vote, notes $9.6M proceeds - Stock Titan
Revelation Biosciences on track for end-of-phase 1 meeting later this year - MSN
Revelation Biosciences (NASDAQ:REVB) Shares Up 2.4% – Here’s Why - Defense World
Revelation Biosciences, Inc. (REVB) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Earnings Flash (REVB) Revolution Beauty Group Reports Fiscal H1 Revenue GBP49.4M - marketscreener.com
Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date - The State Journal-Register
Revelation Biosciences On Track for End-of-Phase 1 Meeting With FDA Later This Year - The Courier-Journal
Can Revelation Biosciences Inc. Equity Warrant stock sustain free cash flow growthLong Setup & Accurate Entry/Exit Alerts - newser.com
How Revelation Biosciences Inc. stock reacts to global recession fearsJuly 2025 News Drivers & High Accuracy Investment Signals - newser.com
Revelation Biosciences submits end-of-phase 1 package to FDA By Investing.com - Investing.com Australia
Revelation Says On Track for FDA Meeting Later This Year - MarketScreener
Revelation Biosciences submits end-of-phase 1 package to FDA - Investing.com
Revelation Biosciences (NASDAQ: REVB) Advances Gemini AKI Program With FDA Phase 1 Meeting - Stock Titan
Chart based analysis of Revelation Biosciences Inc. Equity Warrant trends2025 Valuation Update & Precise Buy Zone Identification - newser.com
How Revelation Biosciences Inc. Equity Warrant stock performs in weak economyGold Moves & Short-Term Trading Alerts - newser.com
How Revelation Biosciences Inc. Equity Warrant stock reacts to oil pricesWall Street Watch & Fast Gaining Stock Strategy Reports - newser.com
How institutional buying supports Revelation Biosciences Inc. Equity Warrant stockWeekly Trend Report & Intraday High Probability Setup Alerts - newser.com
Using RSI to spot recovery in Revelation Biosciences Inc. Equity Warrant2025 Market Trends & Expert Curated Trade Ideas - newser.com
Using Bollinger Bands to evaluate Revelation Biosciences Inc. Equity Warrant2025 Volume Leaders & High Conviction Investment Ideas - newser.com
大文字化:
|
ボリューム (24 時間):